01 Communique Provides Quarterly Update on Business Developments and Third Quarter Fiscal 2021 Results
01 Communique Laboratory Inc. (OONEF) reported third quarter 2021 results, highlighting a substantial revenue increase to $749,324 year-to-date from $349,827 in 2020. Despite a quarterly revenue decline to $211,831, the company emphasizes growth in recurring subscription revenue. A net loss of $228,762 reflects an increase compared to the previous year, but year-to-date losses decreased. The company is advancing its IronCAP™ product and expanding its Asia-Pacific operations, aiming for further subscriber and revenue growth.
- Year-to-date revenue increased by 114% to $749,324 from $349,827 in 2020.
- Recurring subscription revenue is driving growth, reflecting consistent business model evolution.
- IronCAP™ product development and marketing efforts are poised for future revenue generation.
- Third quarter revenue decreased by $23,329 from the previous year to $211,831.
- Increased net loss of $228,762 compared to $39,816 in Q3 2020.
- Adjusted loss increased by $141,307 in Q3 2021.
TORONTO, ON / ACCESSWIRE / September 9, 2021 / 01 Communique Laboratory Inc. (the "Company") (TSXV:ONE)(OTCQB:OONEF) one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era is pleased to report the Company's third quarter 2021 results as it continues to move forward building its business in Asia-Pacific along with an increase in its investment in IronCAP™.
Andrew Cheung, CEO of 01 Communique, stated, "We have seen our revenue more than double year to date to
Third quarter 2021 results:
The loss for the third quarter was
The adjusted loss for the third quarter was
- During the third quarter 2020 the majority of the revenue recognized was for server licenses, which are a one-time amount. For the third quarter 2021 the majority of revenue is the result of recurring subscription revenue. Over the past year our Asia-Pacific business has seen growth from our remote access service with an increase in both subscriber numbers and recurring revenue.
- There was an increase in sales and marketing expenses as we added sales and marketing personnel to work with existing partners and build new partnerships with companies for the integration of the IronCAP™ API with third party applications.
- Research and development expenses were increased to complete development of DoMobile V4 for the Japanese market which was launched on July 28th and for development of the business version of IronCAP X™ scheduled for release later this quarter in October.
- Cash and cash equivalents as at July 31, 2021 were
$1,161,785 compared to$914,057 as at April 30, 2020 an increase of$247,728. T he Company used$156,135 t o fund the adjusted loss for the quarter. The exercise of warrants provided the Company with$311,337 of working capital.
The Company expects to make significant investments in Company infrastructure over the next few years to support the growth of the business including marketing, sales and business development, R&D, finance and business processes.
Conference Call Reminder and Information:
01 Communique will host a live teleconference allowing for questions and answers later today at 10:00AM EST (September 9, 2021) to discuss the Company's results as well as providing an update on the business prospects for IronCAP™ and IronCAP X™.
Browser (please cut-and-paste the following link into your browser):
https://us02web.zoom.us/j/83272630612?pwd=ZGRGMU5aWUY0Z3N3SFgvT2s0VlVrZz09
Passcode: ironcap21
Dial-in:
Within Canada (647) 374-4685 or (647) 558-0588
Within the USA (646) 558 8656 or (669) 900 9128
Webinar ID when prompted is 832 7263 0612
Passcode: 724051661
About 01 Communique
Established in 1992, 01 Communique (TSX-V: ONE; OTCQB: OONEF) has always been at the forefront of technology. The Company's cyber security business unit focuses on post-quantum cybersecurity with the development of its IronCAP™ technology. IronCAP™'spatent-pending cryptographic system is an advanced Goppa code-based post-quantum cryptographic technology that can be implemented on classical computer systems as we know them today while at the same time can also safeguard against attacks in the future post-quantum world of computing. The Company's remote access business unit provides its customers with a suite of secure remote access services and products under its I'm InTouch and I'm OnCall product offerings. The remote access offerings are protected in the U.S.A. by its patents #6,928,479 / #6,938,076 / #8,234,701; in Canada by its patents #2,309,398 / #2,524,039 and in Japan by its patent #4,875,094. For more information, visit the Company's web site at www.ironcap.ca and www.01com.com.
Cautionary Note Regarding Forward-looking Statements.
Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. Such statements include statements regarding the commercial success of IronCAP X™, the future of quantum computers and their impact on the Company's product offering, the functionality of the Company's products and the intended product lines for the Company's technology and the potential licensing of the Company's technology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk and Uncertainties" in the Company's Management`s Discussion and Analysis document filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances.
Neither TSX Venture Exchange ("TSX-V") nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
INVESTOR CONTACT:
Brian Stringer
Chief Financial Officer
01 Communique
(905) 795-2888 x204
Brian.stringer@01com.com
01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Financial Position
Unaudited
As at July 31, 2021 and October 31, 2020
31-July-21 | 31-Oct-20 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 1,161,785 | $ | 962,337 | ||||
Guaranteed investment certificate | - | 60,000 | ||||||
Accounts receivable | 231,469 | 202,974 | ||||||
Prepaid expenses and other assets | 28,234 | 25,343 | ||||||
1,421,488 | 1,250,654 | |||||||
Plant and equipment | 139,084 | 35,253 | ||||||
Total assets | $ | 1,560,572 | $ | 1,285,907 | ||||
Liabilities and Shareholders' Deficit | ||||||||
Current liabilities | ||||||||
Accounts payable and accrued liabilities | $ | 168,184 | $ | 151,111 | ||||
Deferred revenue | 8,665 | 7,679 | ||||||
Lease liability | 42,822 | 18,704 | ||||||
219,671 | 177,494 | |||||||
Non-current liabilities | ||||||||
Lease liability | 77,066 | - | ||||||
CEBA loan payable | 60,000 | - | ||||||
Total liabilities | 137,066 | 177,494 | ||||||
Shareholders' deficit | ||||||||
Share capital | 43,963,581 | 43,395,752 | ||||||
Contributed surplus | 5,824,110 | 5,717,636 | ||||||
Warrants | 93,532 | 266,135 | ||||||
Deficit | (48,677,388 | ) | (48,271,110 | ) | ||||
1,203,835 | 1,108,413 | |||||||
Total liabilities and shareholders' deficit | $ | 1,560,572 | $ | 1,285,907 |
01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Operations and Comprehensive Income
Unaudited
For the 3 and 9 month periods ended July 31, 2021 and 2020
three months ended | nine months ended | |||||||||||||||
31-Jul-21 | 31-Jul-20 | 31-Jul-21 | 31-Jul-20 | |||||||||||||
Revenue | $ | 211,831 | $ | 235,160 | $ | 722,324 | $ | 349,827 | ||||||||
Expenses: | ||||||||||||||||
Selling, general and administrative | 207,909 | 111,153 | 570,400 | 415,724 | ||||||||||||
Research and development | 209,766 | 120,717 | 485,871 | 323,215 | ||||||||||||
Withholding taxes | 20,660 | 22,900 | 70,651 | 34,172 | ||||||||||||
438,334 | 254,770 | 1,126,922 | 773,111 | |||||||||||||
Loss before accretion on liability component of debenture, interest, and other income | (226,503 | ) | (19,610 | ) | (404,598 | ) | (423,284 | ) | ||||||||
Interest on debenture | - | 15,000 | - | 45,000 | ||||||||||||
Accretion on liability portion of debenture | - | 4,535 | - | 13,832 | ||||||||||||
Loss before other income and expense | (226,503 | ) | (39,145 | ) | (404,598 | ) | (482,116 | ) | ||||||||
Interest income | (2,166 | ) | - | (751 | ) | 875 | ||||||||||
Interest expense | 1,595 | 671 | 2,431 | 2,100 | ||||||||||||
Loss for the period and comprehensive loss | $ | (228,762 | ) | $ | (39,816 | ) | $ | (406,278 | ) | $ | (483,341 | ) | ||||
Loss per common share | ||||||||||||||||
Basic | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||
Diluted | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||
Weighted average number of common shares Basic | 93,278,000 | 80,985,653 | 92,246,000 | 80,243,450 | ||||||||||||
Diluted | 93,278,000 | 80,985,653 | 92,246,000 | 80,243,450 |
01 Communique Laboratory Inc.
SELECTED FINANCIAL INFORMATION
Consolidated Statements of Cash Flows
Unaudited
For the 3 and 9 month periods ended July 31, 2021 and 2020
three months ended | nine months ended | |||||||||||||||
31-Jul-21 | 31-Jul-20 | 31-Jul-21 | 31-Jul-20 | |||||||||||||
Cash provided by (used in): | ||||||||||||||||
Operating activities: | ||||||||||||||||
Comprehensive loss for the period | $ | (228,762 | ) | $ | (39,816 | ) | $ | (406,278 | ) | $ | (483,341 | ) | ||||
Adjustments to reconcile loss for the period to | ||||||||||||||||
net cash flows from operating activities: | ||||||||||||||||
Depreciation of property and equipment | 1,777 | 1,388 | 5,431 | 4,340 | ||||||||||||
Amortization of right-of-use asset | 11,219 | 11,061 | 34,298 | 33,183 | ||||||||||||
Stock-based compensation expense | 70,850 | 23,600 | 136,614 | 96,750 | ||||||||||||
Accretion on liability portion of debenture | - | 4,535 | - | 13,832 | ||||||||||||
Change in non-cash working capital | 96,870 | (185,167 | ) | (13,327 | ) | (183,340 | ) | |||||||||
(48,046 | ) | (185,274 | ) | (243,262 | ) | (519,451 | ) | |||||||||
Financing activities: | ||||||||||||||||
Exercise of stock options | 41,750 | - | 43,500 | - | ||||||||||||
Exercise of warrants | 269,587 | - | 321,587 | - | ||||||||||||
Proceeds from private placement | - | 202,000 | - | 202,000 | ||||||||||||
Issuance costs on private placement | - | (10,438 | ) | - | (10,438 | ) | ||||||||||
Proceeds from loan | - | - | 60,000 | - | ||||||||||||
Lease payments made | (11,338 | ) | (10,296 | ) | (33,451 | ) | (32,226 | ) | ||||||||
299,999 | 181,266 | 391,636 | 159,336 | |||||||||||||
Investing activities: | ||||||||||||||||
Proceeds from guaranteed investment certificate | - | - | 60,000 | 190,000 | ||||||||||||
Purchase of property and equipment | (4,225 | ) | (266 | ) | (8,926 | ) | (2,417 | ) | ||||||||
(4,225 | ) | (266 | ) | 51,074 | 187,583 | |||||||||||
Increase in cash and cash equivalents | 247,728 | (4,274 | ) | 199,448 | (172,532 | ) | ||||||||||
Cash and cash equivalents, beginning of period | 914,057 | 115,454 | 962,337 | 283,712 | ||||||||||||
Cash and cash equivalents, end of period | $ | 1,161,785 | $ | 111,180 | $ | 1,161,785 | $ | 111,180 |
#
SOURCE: 01 Communique Laboratory Inc.
View source version on accesswire.com:
https://www.accesswire.com/663191/01-Communique-Provides-Quarterly-Update-on-Business-Developments-and-Third-Quarter-Fiscal-2021-Results
FAQ
What were 01 Communique's revenue results for Q3 2021?
How much did 01 Communique's net loss increase in Q3 2021?
What is the year-to-date revenue for 01 Communique as of July 31, 2021?
What significant product development is 01 Communique expecting in October 2021?